Suppr超能文献

微小RNA-30a-5p(miR-30a)通过直接靶向结直肠癌中的致癌性跨膜4超家族成员1(TM4SF1)来调节细胞运动性和上皮-间质转化。

MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.

作者信息

Park Y R, Kim S L, Lee M R, Seo S Y, Lee J H, Kim S H, Kim I H, Lee S O, Lee S T, Kim Sang Wook

机构信息

Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea.

Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju, Jeonbuk, 54896, Republic of Korea.

出版信息

J Cancer Res Clin Oncol. 2017 Oct;143(10):1915-1927. doi: 10.1007/s00432-017-2440-4. Epub 2017 May 20.

Abstract

PURPOSE

Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide, and many oncogenes and tumor suppressor genes are involved in CRC. MicroRNAs (miRNAs) are small non-coding RNAs that can negatively regulate gene expression. Previous studies have revealed that miRNAs regulate the development and progression of many cancers. In this study, we investigated the role of microRNA-30a-5p (miR-30a) in CRC and its unknown mechanisms.

METHODS

qRT-PCR was used to detect miR-30a and TM4SF1 mRNA expression in CRC specimens and cell lines. CRC cell migration and invasion were assessed after transfection with miR-30a or TM4SF1 using wound healing and trans-well migration and invasion assays. Transmembrane-4-L-six-family protein (TM4SF1) was validated as a target of miR-30a in CRC through luciferase reporter assay and bioinformatics algorithms. Moreover, two EMT regulators, E-cadherin and VEGF, were also identified using Western blotting and immunohistochemistry.

RESULTS

We found that miR-30a was down-regulated in CRC tumor tissues and cell lines, and miR-30a was inversely associated with advanced stage and lymph node metastatic status compared with normal tissues. miR-30a decreased migration and invasion in CRC cell lines, and miR-30a overexpression not only down-regulated TM4SF1 mRNA and protein expression, but also inhibited the expression of VEGF and enhanced expression of E-cadherin. We also showed that TM4SF1 was up-regulated in CRC tumor specimens compared with adjacent normal tissues, and TM4SF1 expression was significantly associated with advanced stage and lymph node status compared with adjacent normal tissues.

CONCLUSIONS

These results suggest that miR-30a is an important regulator of TM4SF1, VEGF, and E-cadherin for CRC lymph node metastasis, a potential new therapeutic target in CRC.

摘要

目的

结直肠癌(CRC)是全球癌症死亡的主要原因之一,许多癌基因和肿瘤抑制基因都与CRC有关。微小RNA(miRNA)是一类可负向调控基因表达的小非编码RNA。先前的研究表明,miRNA可调控多种癌症的发生和发展。在本研究中,我们探究了微小RNA-30a-5p(miR-30a)在CRC中的作用及其未知机制。

方法

采用qRT-PCR检测CRC标本和细胞系中miR-30a和TM4SF1 mRNA的表达。使用伤口愈合实验以及Transwell迁移和侵袭实验,评估转染miR-30a或TM4SF1后CRC细胞的迁移和侵袭能力。通过荧光素酶报告基因检测和生物信息学算法,验证跨膜4L6家族蛋白(TM4SF1)是CRC中miR-30a的靶标。此外,还通过蛋白质免疫印迹法和免疫组织化学法鉴定了两种上皮-间质转化(EMT)调节因子E-钙黏蛋白和血管内皮生长因子(VEGF)。

结果

我们发现,miR-30a在CRC肿瘤组织和细胞系中表达下调,与正常组织相比,miR-30a与晚期和淋巴结转移状态呈负相关。miR-30a可降低CRC细胞系的迁移和侵袭能力,miR-30a过表达不仅下调TM4SF1 mRNA和蛋白表达,还抑制VEGF表达并增强E-钙黏蛋白的表达。我们还发现,与相邻正常组织相比,TM4SF1在CRC肿瘤标本中表达上调,且与相邻正常组织相比,TM4SF1表达与晚期和淋巴结状态显著相关。

结论

这些结果表明,miR-30a是CRC淋巴结转移中TM4SF1、VEGF和E-钙黏蛋白的重要调节因子,是CRC潜在的新治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验